Cookson Peirce & Co’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Cookson Peirce & Co’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,930	Closed	-$1.6M	–	263
2024 Q1	$1.6M	Buy	+4,930	New	+$1.21M	0.09%	85
2023 Q3	–	Sell	-78,190	Closed	-$22.3M	–	239
2023 Q2	$22.3M	Buy	+78,190	New	+$21.7M	1.36%	26

Other funds holding SWAV

Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return

UWS

Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Cookson Peirce & Co's SWAV Position: Q2 2024 in Review

Cookson Peirce & Co sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 4,930 shares — an estimated $1.6M sold.

Cookson Peirce & Co first reported a position in SWAV in Q2 2023 and held it in 2 quarters. The position peaked at $22.3M in Q2 2023. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

Cookson Peirce & Co reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Cookson Peirce & Co sold 4,930 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $1.6M.
Cookson Peirce & Co first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2023 and held it in 2 quarters.
Cookson Peirce & Co's Shockwave Medical, Inc. Common Stock position peaked at $22.3M in Q2 2023.
7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Cookson Peirce & Co's 13F filing for Q2 2024, filed 14 Aug 2024.